This Medical News article discusses efforts aimed at developing ovarian cancer screening and prevention strategies.
This cohort study estimates age-specific risks of breast, ovarian, and contralateral breast cancer among carriers of BRCA1 and BRCA2 mutations and evaluates risk modification by family cancer history and location of the mutation within the BRCA gene.
This Evidence Report to support the 2017 US Preventive Services Task Force Recommendation Statement on the screening pelvic examination summarizes current evidence on benefits, accuracy, and harms of periodic screening pelvic examination for gynecologic conditions in asymptomatic, nonpregnant women.
This Viewpoint discusses a recent report from the National Academies of Sciences, Engineering, and Medicine that emphasizes the latest knowledge in ovarian cancer research and recommends approaches that will benefit outcomes for women with or at risk for ovarian cancer.
This study estimates familial risk and heritability of cancer types in a large twin cohort using data from population-based registers in Denmark, Finland, Norway, and Sweden.
This genetic epidemiology study reports that risk of breast and ovarian cancer among women with BRCA1 and BRCA2 mutations varies by mutation type and location.
You currently have no searches saved.